Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-08-12
Germany Medicines With The Active Ingredient Combination Sofosbuvir And Velpatasvir (atc 2026-08-12
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Adalimumab, Atc L04ab04 2026-08-13
Canada Healthpro Canada - 05302 Floor Care Chemicals & Accessories Commencing December 1, 2026 2026-08-13
Hungary Mate Chemicals And Consumables Dbr 2. 2026-08-14
India Empanelment Of Private Hospitals, Eye Centers, Dental Clinics, And Diagnostic Centers For Health Scheme Beneficiaries. Private Hospitals, Eye Centers, Dental Clinics, Diagnostic Centers 2026-08-14
Poland Purchase Of Medical Equipment And Supplies 2026-08-15
Germany Open House Pharmaceutical Discount Contracts Fingolimod In The Strength Of 0.25 Mg, Atc L04ae01 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Dexamfetamine, Atc N06ba02 For The Period April 1st, 2026 - March 31st, 2028 (plus Extension Option 1x12 Months) 2026-08-15
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Lercanidipine, Atc C08ca13 For The Period April 1st, 2026 - March 31st, 2028 (plus Extension Option 1x12 Months) 2026-08-15
Whats app